PMAM
PKBOW

Picton Mahoney Asset Management’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

Picton Mahoney Asset Management’s Portfolio PKBOW Stock Details PKBOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,000
Closed -$9K – 970
2022
Q1 		$9K Hold
20,000
– – ﹤0.01% 912
2021
Q4 		$16K Hold
20,000
– – ﹤0.01% 934
2021
Q3 		$13K Buy
+20,000
New +$15.9K ﹤0.01% 854

Other funds holding PKBOW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Picton Mahoney Asset Management's PKBOW Position: Q2 2022 in Review

Picton Mahoney Asset Management sold out of Peak Bio, Inc. Warrant (PKBOW) in Q2 2022, closing a stake of 20,000 shares — an estimated $9K sold.

Picton Mahoney Asset Management first reported a position in PKBOW in Q3 2021 and held it in 3 quarters. The position peaked at $16K in Q4 2021. 17 funds tracked by Wall St. Rank hold PKBOW as of Q2 2022.

  • Picton Mahoney Asset Management reported no remaining Peak Bio, Inc. Warrant position as of Q2 2022 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 20,000 Peak Bio, Inc. Warrant shares in Q2 2022, an estimated $9K.
  • Picton Mahoney Asset Management first reported a position in Peak Bio, Inc. Warrant in Q3 2021 and held it in 3 quarters.
  • Picton Mahoney Asset Management's Peak Bio, Inc. Warrant position peaked at $16K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q2 2022.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.